In a phase of intense expansion in auditing activities, Di Renzo Regulatory Affairs has taken on new and qualified resources in order to expand its consulting proposal.
In addition to the existing inspection activities according to;
- GMP (both in the production of finished products and active ingredients)
- ISO 13485 (at each stage of the supply chain of a medical device, from its development to its distribution, and post-marketing surveillance)
- GDP (giving support in the start-up phase and in obtaining approval)
- ISO 22716 (good manufacturing practice for cosmetic)
an auditing sub-unit has been established for the implementation phase of the
System for the adaptation to the provisions of the Legislative Decree 231/2001 regarding the administrative liability of companies and / or the verification phase of the System.
As a result of these new acquisitions, Di Renzo Regulatory Affairs can rely on an Auditing office consisting of more than 10 technicians qualified to carry out inspections in accordance with the abovementioned requirements.